Pregnant women who drink a lot of diet soda with saccharin or sucralose are more likely to get gestational diabetes than those who don’t, with saccharin showing the strongest link.
Claim Context
High consumption of sucralose during pregnancy is associated with a 1.49-fold increased odds of gestational diabetes mellitus (GDM), and high consumption of sodium saccharin is associated with a 2.97-fold increased odds, suggesting that specific artificial sweeteners may differentially influence GDM risk.
“High consumption of sucralose... OR=1.49 (95% CI: 1.35–1.36); high consumption of sodium saccharin... OR=2.97 (95% CI: 1.17–1.49).”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether replacing sucralose or saccharin with placebo reduces GDM incidence in pregnant women.
A double-blind RCT of 800 pregnant women with high baseline sweetener intake, randomized to receive either sucralose-free or saccharin-free dietary counseling + placebo foods vs. continued intake, with GDM diagnosis via OGTT at 24–28 weeks and serum sweetener levels as biomarkers.
Whether specific sweeteners (sucralose, saccharin) independently predict GDM after adjusting for total caloric intake and other dietary patterns.
A prospective cohort of 6000 pregnant women with serial dietary assessments using validated tools and biomarker validation (e.g., urinary sucralose/saccharin), tracking GDM incidence while controlling for total sugar intake, BMI trajectory, and gut microbiome changes.
Whether women with GDM had significantly higher exposure to saccharin or sucralose than matched controls.
A matched case-control study of 300 GDM cases and 600 controls, with detailed dietary recall and biomarker analysis of saccharin and sucralose intake during first and second trimesters, controlling for total energy, fiber, and processed food intake.
The prevalence of high saccharin or sucralose intake among women with and without GDM at diagnosis.
A cross-sectional survey of 5000 pregnant women at time of GDM diagnosis or screening, measuring sweetener intake via 24-hour recall and serum biomarkers, comparing prevalence between GDM and non-GDM groups.
Anecdotal patterns of GDM in women with extreme intake of saccharin or sucralose.
A case series of 15 pregnant women with GDM who consumed >500 mg/day of saccharin or sucralose, documenting dietary logs, serum levels, and metabolic profiles.